Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4xlv | ACP | Insulin receptor | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 1.000 | |
| 3dqw | AGS | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.473 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.468 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.458 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.458 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.456 | |
| 3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.456 | |
| 1jkk | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.450 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 |